Angiogenesis
A vaccine targeting angiomotin induces an antibody response which alters tumor vessel permeability and hampers the growth of established tumors
Angiogenic properties of myofibroblasts isolated from normal human skin wounds
Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab
c-ABL modulates MAP kinases activation downstream of VEGFR-2 signaling by direct phosphorylation of the adaptor proteins GRB2 and NCK1
Calpain-mediated vimentin cleavage occurs upstream of MT1-MMP membrane translocation to facilitate endothelial sprout initiation
Clinical, pharmacokinetic and pharmacodynamic evaluations of metronomic UFT and cyclophosphamide plus celecoxib in patients with advanced refractory gastrointestinal cancers
DNA methylation regulates lineage-specifying genes in primary lymphatic and blood endothelial cells
Erratum to: MG624, an a7-nAChR antagonist, inhibits angiogenesis via the Egr-1/FGF2 pathway
Matrix composition regulates three-dimensional network formation by endothelial cells and mesenchymal stem cells in collagen/fibrin materials
Over-expression of BMP4 inhibits experimental choroidal neovascularization by modulating VEGF and MMP-9
Protein kinase CK2 is a regulator of angiogenesis in endometriotic lesions
Soluble HSPB1 regulates VEGF-mediated angiogenesis through their direct interaction
VEGF, PF4 and PDGF are elevated in platelets of colorectal cancer patients